Results showed that siRNA-mediated knockdown of SMAD5 had a promoting effect on CD34+ CML cell proliferation, suggesting that SMAD5 knock-down recapitulates the proliferative effects of miR-155. The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.